Global Haloperidol Market Report By Product (Oral ,Injection), By End User ,Mental Disease ,Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11213972
December 2020
Report Formats:
The global demand for Haloperidol Market is presumed to reach the valuation of nearly USD XX MN by 2027 from USD XX MN in 2020 with a CAGR of XX% under the study period of 2021 - 2027. Whereas with regards to volume, the market was calculated XX K MT in 2020 and foreseen to touch XX K MT by 2027 with a CAGR of XX% during 2021-2027.

Haloperidol is an antipsychotic drug commonly used to treat mental or mood disorders in patients who have schizophrenia. This prescription medicine works by restoring the balance of neurotransmitters or dopamine in the patient's brain. It is taken as an injection, tablet, or an oral solution. This drug is used to manage motor and speech spasms in people with Tourette's syndrome, hallucinations in individuals during alcohol withdrawal, and severe behavioral disorders in children who do not show the expected response to medication therapy. Haloperidol can be used as a veterinary drug as well. If used for the long-term, being a medication with high-potency, routine monitoring of the patient's BMI, blood pressure, fasting blood sugar, and cholesterol is recommended to avoid adverse side effects. 

Market Dynamics 

Growing cases of psychotic disorders like schizophrenia among the global population will be the key driving force for this market's growth. Rising awareness about physical illness due to depression, available treatment methods for mental disorders and symptoms will benefit market growth. The relatively low cost of this drug will further boost the demand for this medication globally. An increasing number of suicide attempts and deaths due to suicide in schizophrenic patients will further propel market growth. High investments in the R&D of antipsychotic drugs and WHO initiatives to promote mental health will be a market booster. The various side effects associated with this medication is the main hindrance to the growth of this market. 

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each segment in the global market of haloperidol.

Market Segmentation

This section of the haloperidol market report  provides detailed data on the segments by analyzing them geographically, thereby assisting the strategist in identifying the target demographics for the respective product or service..

By Product 
  • Oral 
  • Injection 

By End User 
  • Mental Disease 
  • Others

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for Haloperidol market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global Haloperidol Market Share by Region (Representative Graph)

Global Haloperidol Market Share


The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the haloperidol market include Sandoz, Mylan, Teva, Fresenius Kabi, Gland Pharma, Zydus. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
 
METHODOLOGY:

This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications. 

If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . HALOPERIDOL – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Product
           3.7.2 By End User
           3.7.3 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL HALOPERIDOL MARKET ANALYSIS BY PRODUCT
       6.1 Overview by Product
       6.2 Historical and Forecast Data
       6.3 Analysis by Product
       6.4 Oral  Market by Regions
       6.5 Injection  Market by Regions
 
7 . GLOBAL HALOPERIDOL MARKET ANALYSIS BY END USER
       7.1 Overview by End User
       7.2 Historical and Forecast Data
       7.3 Analysis by End User
       7.4 Mental Disease  Market by Regions
       7.5 Others Market by Regions
 
8 . GLOBAL HALOPERIDOL MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview, Historic and Forecast Data
           8.3.2. North America By Segment
           8.3.3. North America By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview, Historic and Forecast Data
           8.4.2. Europe by Segment
           8.4.3. Europe by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview, Historic and Forecast Data
           8.5.2. Asia Pacific by Segment
           8.5.3. Asia Pacific by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
           8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview, Historic and Forecast Data
           8.6.2. Latin America by Segment
           8.6.3. Latin America by Country
           8.6.4. Brazil
           8.6.5. Argentina
           8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview, Historic and Forecast Data
           8.7.2. Middle East & Africa by Segment
           8.7.3. Middle East & Africa by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa
 
9 . COMPETITIVE LANDSCAPE OF THE HALOPERIDOL COMPANIES
       9.1. Haloperidol Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF HALOPERIDOL INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Sandoz
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Mylan
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Teva
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Fresenius Kabi
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Gland Pharma
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Zydus
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Product  (K MT and USD MN)
  • Oral  Market by Geography (K MT and USD MN)
  • Injection  Market by Geography (K MT and USD MN)
  • Analysis Market by End User  (K MT and USD MN)
  • Mental Disease  Market by Geography (K MT and USD MN)
  • Others Market by Geography (K MT and USD MN)
  • Global Haloperidol Market by Geography (K MT and USD MN)
  • North America Market Analysis (K MT and USD MN)
  • United State Market Analysis (K MT and USD MN)
  • Canada Market Analysis (K MT and USD MN)
  • Mexico Market Analysis (K MT and USD MN)
  • Europe Market Analysis (K MT and USD MN)
  • Europe Market Estimate by Country (K MT and USD MN)
  • United Kingdom Market Analysis (K MT and USD MN)
  • France Market Analysis (K MT and USD MN)
  • Germany Market Analysis (K MT and USD MN)
  • Italy Market Analysis (K MT and USD MN)
  • Russia Market Analysis (K MT and USD MN)
  • Spain Market Analysis (K MT and USD MN)
  • Rest of Europe Market Analysis (K MT and USD MN)
  • Asia Pacific Market Analysis (K MT and USD MN)
  • China Market Analysis (K MT and USD MN)
  • Japan Market Analysis (K MT and USD MN)
  • India Market Analysis (K MT and USD MN)
  • South Korea Market Analysis (K MT and USD MN)
  • Australia Market Analysis (K MT and USD MN)
  • Rest of Asia Pacific Market Analysis (K MT and USD MN)
  • Latin America Market Analysis (K MT and USD MN)
  • Brazil Market Analysis (K MT and USD MN)
  • Argentina Market Analysis (K MT and USD MN)
  • Peru Market Analysis (K MT and USD MN)
  • Chile Market Analysis (K MT and USD MN)
  • Rest of Latin America Market Analysis (K MT and USD MN)
  • Middle East & Africa Market Analysis (K MT and USD MN)
  • Saudi Arabia Market Analysis (K MT and USD MN)
  • UAE Market Analysis (K MT and USD MN)
  • Israel Market Analysis (K MT and USD MN)
  • South Africa Market Analysis (K MT and USD MN)
  • Rest of Middle East and Africa Market Analysis (K MT and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of Haloperidol Report
  • Market Research Process
  • Market Research Methodology
  • Global Haloperidol Market Size, by Region (K MT and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product  (K MT and USD MN)
  • Oral  Market by Geography (K MT and USD MN)
  • Injection  Market by Geography (K MT and USD MN)
  • Global Market Analysis by End User  (K MT and USD MN)
  • Mental Disease  Market by Geography (K MT and USD MN)
  • Others Market by Geography (K MT and USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials